Categories
Uncategorized

Pediatric Thyroid Nodules & Cancers: 2 Clinical Cases, 2 Perspectives with Drs. Bauer & Wasserman (Part 1)

Part 1: Evaluating Pediatric Thyroid Nodules

When a thyroid nodule is discovered in a child, how should clinicians approach the diagnostic workup, and where do adult guidelines fall short? In this episode of Voices of Wisdom, host Dr. Dana Hartl welcomes pediatric endocrinologists Dr. Andrew Bauer and Dr. Jonathan Wasserman for a case-based discussion of pediatric thyroid nodules and cancer. Beginning with a 12-year-old boy presenting with a 2 cm thyroid nodule, they explore the nuances of ultrasound interpretation, the higher malignancy risk associated with pediatric nodules and the importance of considering a child’s age and thyroid size when deciding whether to perform fine-needle aspiration.

As the case progresses to Bethesda IV cytology, the conversation turns to the role of molecular testing, inherited cancer predisposition syndromes and surgical decision-making. Drs. Bauer and Wasserman consider when lobectomy may be appropriate, how genetic findings can influence treatment and why active surveillance remains a challenging proposition in pediatric patients. Their discussion also reveals an important evolution in clinical thinking: selected children with low-risk papillary thyroid carcinoma may not require completion thyroidectomy, provided appropriate postoperative assessment and surveillance are maintained.

The discussion concludes with a thoughtful examination of long-term follow-up and family screening. Drawing on clinical experience and population screening data, the guests explain why identifying a thyroid nodule does not necessarily mean that intervention is warranted. They also acknowledge the anxiety families experience when a child receives a cancer diagnosis and the importance of balancing reassurance with evidence-based care. Throughout the episode, a central message emerges: pediatric thyroid care requires individualized risk assessment, experienced multidisciplinary teams and shared decision-making that considers both clinical outcomes and the family’s perspective.